PHIO Stock Predictions
| Recent PHIO Stock Price | PHIO Stock Predictions | |
| $6.85 |  -12.41% |
$6.00 |
| Recent PHIO Analyst Ratings Breakdown, Making PHIO Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 1 | 1 | 1 | 1 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 0 | 0 | 0 | 0 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the PHIO stock predictions from the analysts covering Phio Pharmaceuticals Corp, we have collected all of the individual PHIO stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 1 different analysts covering PHIO (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since PHIO stock predictions may vary widely, another useful metric to consider is the median PHIO stock prediction, which represents the price at which half of the analysts
made PHIO stock predictions that were higher and half made PHIO stock predictions that were lower. This makes for a different take on the PHIO stock predictions out there, as compared to average or mean.
And that median across all the individual PHIO stock predictions was: $6.0 as of 2023-01-27.
The very highest of the PHIO stock predictions for one year price target was $6.0, while the very lowest of the PHIO stock predictions in the analyst group was
$6.0 (with a standard deviation of $0.0). Get the latest Zacks research report on PHIO — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• GLT Stock Predictions
• DOX Stock Predictions
• SOI Stock Predictions
• FMS Stock Predictions
• AGS Stock Predictions
• SCWX Stock Predictions
• CAPL Stock Predictions
• CONN Stock Predictions
• LX Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free Email Alerts:
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 83rd percentile
(ranked higher than approx. 83% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
